Showing 2,841 - 2,860 results of 3,735 for search '"endocrinology"', query time: 0.06s Refine Results
  1. 2841
  2. 2842
  3. 2843
  4. 2844
  5. 2845
  6. 2846
  7. 2847
  8. 2848
  9. 2849
  10. 2850
  11. 2851
  12. 2852
  13. 2853
  14. 2854

    Elevated Fasting C-Peptide Levels Correlate with Increased 10-Year Risk of Atherosclerotic Cardiovascular Disease in Newly Diagnosed Type 2 Diabetes Patients by Zha XY, Wei CS, Dong JJ, Wu JZ, Xie LX, Xu ZH, Zheng HQ, Huang DB, Lai PB

    Published 2025-01-01
    “…Xiao-Yun Zha, Chang-Shun Wei, Jia-Jia Dong, Jin-Zhi Wu, Liang-Xiao Xie, Ze-Hong Xu, Hua-Qiang Zheng, Duo-Bin Huang, Peng-Bin Lai The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of ChinaCorrespondence: Peng-Bin Lai, The First Department of Endocrinology and Metabolism, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, 363000, People’s Republic of China, Tel +8613709398727, Email 13709398727@163.comPurpose: This study aims to analyze the impact of serum C-peptide levels in patients with newly diagnosed type 2 diabetes (T2DM) on the 10-year risk of atherosclerotic cardiovascular disease (ASCVD).Patients and Methods: A total of 1923 patients with newly diagnosed T2DM were selected and categorized into four groups based on the interquartile range of fasting C-peptide (FCP) levels: Q1 group (FCP≤ 0.568 ng/mL), Q2 group (0.568 < FCP≤ 0.751 ng/mL), Q3 group (0.751 < FCP≤ 0.980 ng/mL), and Q4 group (FCP > 0.980 ng/mL). …”
    Get full text
    Article
  15. 2855
  16. 2856
  17. 2857
  18. 2858
  19. 2859
  20. 2860